Skip to content

Director Dealings: Altus Strategies, AEX Gold, Oxford BioDynamics

Director Dealings: Altus Strategies, AEX Gold, Oxford BioDynamics

In the first of our new weekly series, James Norris looks at director’s buying shares in their own company over the last week.

Altus Strategies (AIM: ALS, TSX-V: ALTS, OTCQX: ALTUF) announced on 18 February that CEO Steven Poulton bought 75,795 ordinary shares of £0.05 each at an average price of 57.91p per share, for a total purchase value of £43,889. On 17 February, he bought 89,290 shares, worth A$208,688. The transactions give Poulton, and persons closely associated with him, an increase in total shareholding to 6,600,000 ordinary shares, representing 5.63% of the company’s outstanding issued ordinary share capital.

Adriatic Metals (ASX:ADT, LSE:ADT1, OTCQX:ADMLF), a precious and base metals developer that is advancing the world-class Vares Silver Project in Bosnia & Herzegovina, as well as the Raska Zinc-Silver Project in Serbia, announced on 18 February that non-executive director Peter Bilbe is selling 70,100 CHESS Depository Interests (foreign company ordinary share equivalents available on ASX) in the company. The transaction is worth A$161,583. The Vares Silver Project is fully funded to production, which is expected in Q2 2023. The 2021 Project Definitive Feasibility Study boasts robust economics of US$1,062 million post-tax NPV8, 134% IRR and a capex of US$168 million. Concurrent with ongoing construction activities, the Company continues to explore across its highly prospective 41 km2 concession package.

AEX Gold Inc. (AIM: AEXG; TSXV: AEX), which engages in the acquisition, exploration and development of gold properties in Greenland, has announced that non-executive director David Neuhauser has acquired a total of 27,500 common shares of no par value in the company for an average price of C$0.53, through Livermore Partners LLC, of which he is managing director. The transaction brings Livermore Partners LLC’s total holding to 11,855,710 shares, 6.69% of the capital in the company. AEX has a portfolio of gold assets covering 4,090 km2, the largest portfolio of gold assets in Southern Greenland covering the two known gold belts in the region. Its main asset is a 100% interest in the Nalunaq Project, an advanced exploration stage property with an exploitation licence.

Tritax EuroBox (LSE: BOXE), a property investment fund focused on logistics and distribution centres across continental Europe, which is benefiting from a structural shift to online shopping, announced on 16 February that non-executive director Robert Orr has bought 48,000 ordinary shares at the price of 103.10p. The Tritax EuroBox fund portfolio value stands at €841.6m; sister fund Tritax BigBox, the UK’s number one investor in high-quality UK logistics assets, has a portfolio value of £4.4bn.

Kistos (LSE: KIST), the low carbon intensity energy producer pursuing a strategy to acquire assets with a role in energy transition, announced on 15 February that executive chairman Andrew Austin has bought 150,000 ordinary shares of 10p each in the market at a price of £3.27 per share for the account of his self-invested personal pension scheme. The acquisition increase Austin’s beneficial interests in the capital of the company from 17.07% to 17.25%.

Oxford BioDynamics (LSE: OBD), a biotechnology company with a proprietary epigenetic biomarker discovery platform EpiSwitch, announced on 15 February that COO Thomas Guiel had bought 50,000 Ordinary Shares of 1 pence each at an average price of 27.9p per share, over three days. As a result of this transaction, Guiel now has a total of 50,000 shares, representing 0.05% of the company’s current issued share capital.

Share this article

Invest with these platforms

Hargreaves Lansdown

IG

Interactive Brokers

Interactive Investor

Charles Stanley

IG

Interactive Brokers

Charles Stanley

Looking for great investing ideas? Get our free newsletter.

This article does not constitute investment advice.  Do your own research or consult a professional advisor.

Learn with our free 'How to' Guides

Our latest in-depth company reports

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

Aquis
CME Group
FP Markets
Pepperstone
Schroders

aberdeen
WisdomTree
ARK
Plus500
CMC Markets
Back To Top